Search hospitals > Florida > West Palm Beach
Florida Cancer Specialists
Claim this profileWest Palm Beach, Florida 33401
Global Leader in Non-Small Cell Lung Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Cancer
Conducts research for Lymphoma
126 reported clinical trials
8 medical researchers
Summary
Florida Cancer Specialists is a medical facility located in West Palm Beach, Florida. This center is recognized for care of Non-Small Cell Lung Cancer, Lung Cancer, Breast Cancer, Cancer, Lymphoma and other specialties. Florida Cancer Specialists is involved with conducting 126 clinical trials across 116 conditions. There are 8 research doctors associated with this hospital, such as Viralkumar Bhanderi, Shachar Peles, Todd Gersten, and Eric Harris.Area of expertise
1Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
EGFR positive
2Lung Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
Top PIs
Viralkumar BhanderiFlorida Cancer Specialists4 years of reported clinical research
Studies Lymphoma
Studies Solid Tumors
13 reported clinical trials
42 drugs studied
Shachar PelesFlorida Cancer Specialists East2 years of reported clinical research
Studies Lymphoma
Studies Multiple Myeloma
10 reported clinical trials
41 drugs studied
Todd GerstenFlorida Cancer Specialists WPB4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
7 reported clinical trials
15 drugs studied
Eric HarrisFlorida Cancer Specialists6 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
5 reported clinical trials
7 drugs studied
Clinical Trials running at Florida Cancer Specialists
Non-Small Cell Lung Cancer
Breast Cancer
Lung Cancer
Cancer
Lymphoma
Tumors
Follicular Lymphoma
Colorectal Cancer
Small Cell Lung Cancer
Leukemia
ONC-392 vs Chemotherapy
for Lung Cancer
The goal of this Phase 3 clinical trial is study the safety and efficacy of the nextgen anti-CTLA-4 antibody, gotistobart (ONC-392/BNT316), in patients with metastatic non-small cell lung cancer who have disease progressed on anti-PD-1/PD-L1 antibody based therapy. The study will test whether gotistobart, in comparison with chemotherapy agent docetaxel, could prolong the life for NSCLC patients. Patients will be randomized to be treated with either gotistobart or docetaxel, IV infusion, once every 21 days, for up to 17 cycles in approximately one year.
Recruiting2 awards Phase 310 criteria
AK112
for Non-Small Cell Lung Cancer
A Randomized, Double-blind, Multi-center, Phase III Clinical Study of Ivonescimab (SMT112 or AK112) or Placebo Plus Pemetrexed and Carboplatin in Patients With EGFR-mutant Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer Who Have Progressed on or Following Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Treatment (HARMONi)
Recruiting1 award Phase 310 criteria
APL-101
for Lung Cancer
Recruiting1 award Phase 211 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Florida Cancer Specialists?
Florida Cancer Specialists is a medical facility located in West Palm Beach, Florida. This center is recognized for care of Non-Small Cell Lung Cancer, Lung Cancer, Breast Cancer, Cancer, Lymphoma and other specialties. Florida Cancer Specialists is involved with conducting 126 clinical trials across 116 conditions. There are 8 research doctors associated with this hospital, such as Viralkumar Bhanderi, Shachar Peles, Todd Gersten, and Eric Harris.